MARINEMAX INC (HZO) Fundamental Analysis & Valuation

NYSE:HZO • US5679081084

26.35 USD
-0.85 (-3.12%)
At close: Mar 12, 2026
26.35 USD
0 (0%)
After Hours: 3/12/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This HZO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

HZO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 124 industry peers in the Specialty Retail industry. HZO may be in some trouble as it scores bad on both profitability and health. HZO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. HZO Profitability Analysis

1.1 Basic Checks

  • HZO had positive earnings in the past year.
  • In the past year HZO had a positive cash flow from operations.
  • Of the past 5 years HZO 4 years were profitable.
  • In multiple years HZO reported negative operating cash flow during the last 5 years.
HZO Yearly Net Income VS EBIT VS OCF VS FCFHZO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • HZO has a worse Return On Assets (-2.37%) than 62.10% of its industry peers.
  • The Return On Equity of HZO (-6.18%) is comparable to the rest of the industry.
  • HZO's Return On Invested Capital of 2.27% is in line compared to the rest of the industry. HZO outperforms 46.77% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HZO is significantly below the industry average of 13.59%.
Industry RankSector Rank
ROA -2.37%
ROE -6.18%
ROIC 2.27%
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
HZO Yearly ROA, ROE, ROICHZO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • HZO has a Operating Margin (2.94%) which is in line with its industry peers.
  • HZO's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 31.59%, HZO is not doing good in the industry: 60.48% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of HZO has grown nicely.
Industry RankSector Rank
OM 2.94%
PM (TTM) N/A
GM 31.59%
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
HZO Yearly Profit, Operating, Gross MarginsHZO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. HZO Health Analysis

2.1 Basic Checks

  • HZO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, HZO has less shares outstanding
  • Compared to 5 years ago, HZO has about the same amount of shares outstanding.
  • The debt/assets ratio for HZO is higher compared to a year ago.
HZO Yearly Shares OutstandingHZO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
HZO Yearly Total Debt VS Total AssetsHZO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.81, we must say that HZO is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.81, HZO is in line with its industry, outperforming 46.77% of the companies in the same industry.
  • HZO has a debt to FCF ratio of 5.88. This is a neutral value as HZO would need 5.88 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 5.88, HZO is doing good in the industry, outperforming 61.29% of the companies in the same industry.
  • A Debt/Equity ratio of 1.13 is on the high side and indicates that HZO has dependencies on debt financing.
  • HZO's Debt to Equity ratio of 1.13 is in line compared to the rest of the industry. HZO outperforms 41.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 5.88
Altman-Z 1.81
ROIC/WACC0.26
WACC8.73%
HZO Yearly LT Debt VS Equity VS FCFHZO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.19 indicates that HZO should not have too much problems paying its short term obligations.
  • HZO has a Current ratio (1.19) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.29 indicates that HZO may have some problems paying its short term obligations.
  • HZO's Quick ratio of 0.29 is on the low side compared to the rest of the industry. HZO is outperformed by 73.39% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.29
HZO Yearly Current Assets VS Current LiabilitesHZO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. HZO Growth Analysis

3.1 Past

  • HZO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.62%.
  • HZO shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.26% yearly.
  • HZO shows a decrease in Revenue. In the last year, the revenue decreased by -1.10%.
  • Measured over the past years, HZO shows a quite strong growth in Revenue. The Revenue has been growing by 8.87% on average per year.
EPS 1Y (TTM)-77.62%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-223.53%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%7.84%

3.2 Future

  • The Earnings Per Share is expected to grow by 48.43% on average over the next years. This is a very strong growth
  • HZO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.83% yearly.
EPS Next Y-12.09%
EPS Next 2Y38.89%
EPS Next 3Y48.43%
EPS Next 5YN/A
Revenue Next Year2.85%
Revenue Next 2Y3.44%
Revenue Next 3Y3.83%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HZO Yearly Revenue VS EstimatesHZO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
HZO Yearly EPS VS EstimatesHZO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

5

4. HZO Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 56.06, HZO can be considered very expensive at the moment.
  • HZO's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of HZO to the average of the S&P500 Index (25.71), we can say HZO is valued expensively.
  • Based on the Price/Forward Earnings ratio of 16.07, the valuation of HZO can be described as correct.
  • Based on the Price/Forward Earnings ratio, HZO is valued a bit cheaper than the industry average as 69.35% of the companies are valued more expensively.
  • HZO's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.82.
Industry RankSector Rank
PE 56.06
Fwd PE 16.07
HZO Price Earnings VS Forward Price EarningsHZO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 73.39% of the companies in the same industry are more expensive than HZO, based on the Enterprise Value to EBITDA ratio.
  • 95.97% of the companies in the same industry are more expensive than HZO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.14
EV/EBITDA 6.7
HZO Per share dataHZO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • HZO's earnings are expected to grow with 48.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.89%
EPS Next 3Y48.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HZO Dividend Analysis

5.1 Amount

  • No dividends for HZO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HZO Fundamentals: All Metrics, Ratios and Statistics

MARINEMAX INC

NYSE:HZO (3/12/2026, 8:04:00 PM)

After market: 26.35 0 (0%)

26.35

-0.85 (-3.12%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners98.57%
Inst Owner Change-1.3%
Ins Owners2.77%
Ins Owner Change14.83%
Market Cap580.49M
Revenue(TTM)2.35B
Net Income(TTM)-57.62M
Analysts81.54
Price Target33.22 (26.07%)
Short Float %18.19%
Short Ratio8.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-81.02%
Min EPS beat(2)-230.66%
Max EPS beat(2)68.62%
EPS beat(4)2
Avg EPS beat(4)-34.43%
Min EPS beat(4)-230.66%
Max EPS beat(4)83.44%
EPS beat(8)4
Avg EPS beat(8)-4.44%
EPS beat(12)5
Avg EPS beat(12)-10.44%
EPS beat(16)8
Avg EPS beat(16)-4.53%
Revenue beat(2)2
Avg Revenue beat(2)2.95%
Min Revenue beat(2)2.61%
Max Revenue beat(2)3.28%
Revenue beat(4)3
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-12.47%
Max Revenue beat(4)8.06%
Revenue beat(8)4
Avg Revenue beat(8)-0.78%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)0.38%
PT rev (1m)3.64%
PT rev (3m)5.56%
EPS NQ rev (1m)-44%
EPS NQ rev (3m)-55.31%
EPS NY rev (1m)-21.81%
EPS NY rev (3m)-20.81%
Revenue NQ rev (1m)0.93%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 56.06
Fwd PE 16.07
P/S 0.25
P/FCF 3.14
P/OCF 2.46
P/B 0.62
P/tB 1.57
EV/EBITDA 6.7
EPS(TTM)0.47
EY1.78%
EPS(NY)1.64
Fwd EY6.22%
FCF(TTM)8.38
FCFY31.81%
OCF(TTM)10.7
OCFY40.61%
SpS106.49
BVpS42.34
TBVpS16.84
PEG (NY)N/A
PEG (5Y)N/A
Graham Number21.16
Profitability
Industry RankSector Rank
ROA -2.37%
ROE -6.18%
ROCE 4.7%
ROIC 2.27%
ROICexc 2.45%
ROICexgc 3.41%
OM 2.94%
PM (TTM) N/A
GM 31.59%
FCFM 7.87%
ROA(3y)1.56%
ROA(5y)6.94%
ROE(3y)4.15%
ROE(5y)12.76%
ROIC(3y)4.73%
ROIC(5y)10.19%
ROICexc(3y)5.21%
ROICexc(5y)12.96%
ROICexgc(3y)7.5%
ROICexgc(5y)19.19%
ROCE(3y)9.35%
ROCE(5y)16.79%
ROICexgc growth 3Y-45.93%
ROICexgc growth 5Y-23.4%
ROICexc growth 3Y-45.55%
ROICexc growth 5Y-25.45%
OM growth 3Y-27.03%
OM growth 5Y-9.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.37%
GM growth 5Y4.23%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 5.88
Debt/EBITDA 8.8
Cap/Depr 101.56%
Cap/Sales 2.18%
Interest Coverage 0.92
Cash Conversion 197.58%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.29
Altman-Z 1.81
F-Score5
WACC8.73%
ROIC/WACC0.26
Cap/Depr(3y)139.54%
Cap/Depr(5y)177.5%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.62%
EPS 3Y-54.22%
EPS 5Y-24.26%
EPS Q2Q%-223.53%
EPS Next Y-12.09%
EPS Next 2Y38.89%
EPS Next 3Y48.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y0.02%
Revenue growth 5Y8.87%
Sales Q2Q%7.84%
Revenue Next Year2.85%
Revenue Next 2Y3.44%
Revenue Next 3Y3.83%
Revenue Next 5YN/A
EBIT growth 1Y-53.43%
EBIT growth 3Y-27.02%
EBIT growth 5Y-1%
EBIT Next Year20.18%
EBIT Next 3Y14.51%
EBIT Next 5YN/A
FCF growth 1Y182.68%
FCF growth 3Y-12.94%
FCF growth 5Y-47.23%
OCF growth 1Y252.08%
OCF growth 3Y-1.68%
OCF growth 5Y-24.9%

MARINEMAX INC / HZO FAQ

Can you provide the ChartMill fundamental rating for MARINEMAX INC?

ChartMill assigns a fundamental rating of 3 / 10 to HZO.


What is the valuation status of MARINEMAX INC (HZO) stock?

ChartMill assigns a valuation rating of 5 / 10 to MARINEMAX INC (HZO). This can be considered as Fairly Valued.


Can you provide the profitability details for MARINEMAX INC?

MARINEMAX INC (HZO) has a profitability rating of 3 / 10.


Can you provide the financial health for HZO stock?

The financial health rating of MARINEMAX INC (HZO) is 3 / 10.